News

CENTOGENE Announces Pricing of Primary and Secondary Public Offering of Common Shares

Jul 09, 2020

CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, July 09, 2020 (GLOBE NEWSWIRE) - Centogene N.V. (Nasdaq: CNTG)...

CENTOGENE Announces the Scientific Publication of a holistic solution in the preventive testing of COVID-19

Jul 09, 2020

CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, July 09, 2020 (Globe Newswire) - Centogene N.V. (Nasdaq: CNTG), a...

CENTOGENE Announces Proposed Primary and Secondary Public Offering of Common Shares

Jul 08, 2020

CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, July 07, 2020 (Globe Newswire) - Centogene N.V. (Nasdaq: CNTG), a...

CENTOGENE Announces Partnership with OESIS Network for COVID-19 PCR Testing for US School Populations

Jul 06, 2020

CAMBRIDGE, Mass. and SANTA MONICA, California, July 06, 2020 (Globe Newswire) – Centogene N.V. (Nasdaq: CNTG), a...

CENTOGENE Receives FDA Emergency Use Authorization for COVID-19 Molecular Diagnostic Test

Jul 02, 2020

Cambridge, MA, USA & Rostock/Berlin, Germany, July 2, 2020 (GLOBE NEWSWIRE) – Centogene N.V. (Nasdaq: CNTG), a...

CENTOGENE, Lufthansa, and Fraport Launch the First Walk-In COVID-19 Testing Facility in Germany at Frankfurt Airport

Jun 29, 2020

Cambridge, MA, USA & Rostock/Berlin, Germany, June 29, 2020 (Globe Newswire)

Lufthansa becomes first globally leading...

CENTOGENE, Lufthansa und Fraport eröffnen erstes Walk-In Corona-Testzentrum (FCT) in Deutschland am Frankfurter Flughafen

Jun 29, 2020

Cambridge, MA, USA & Rostock, Berlin, Deutschland, 29. Juni 2020

Richtungsweisende Kooperation bietet ab sofort das...

CENTOGENE Announces Change in Supervisory Board

Jun 23, 2020

Cambridge, MA, USA & Rostock/Berlin, Germany, June 23, 2020 (Globe Newswire) – Centogene N.V. (Nasdaq: CNTG), a...

Partnership for OESIS Network

Jun 16, 2020

CAMBRIDGE, Mass. and SANTA MONICA, California, June 16, 2020 - In light of the current Coronavirus situation, the OESIS...

CENTOGENE Reports First-Quarter 2020 Financial Results and Corporate Progress

Jun 15, 2020

Cambridge, MA, USA & Rostock/Berlin, Germany, June 15, 2020 (Globe Newswire) – Centogene N.V. (Nasdaq: CNTG), a...

1
2
3
....
15
Next

Press Contact

For further inquiries please contact:

Ben Legg

Corporate Communications

Send Email

Subscribe to our Newsletter

First Name

Last Name

Country

To receive the latest news and developments in clinical diagnostics and scientific breakthroughs in the rare disease field please click subscribe. After that, you will receive an email with a confirmation link. Once you have clicked on that link, we will inform you about our products, services and upcoming events per e-mail. You can unsubscribe from the newsletter with effect for the future at any time using the unsubscribe link contained in every newsletter.

Scientific articles

Successful Monitoring of Gaucher Disease

Biomarkers are key tools in establishing a diagnosis and monitoring rare disorders. The lipid metabolite Lyso-Gb1 has long been known as an excellent diagnostic biomarker. In a recent study, which was initiated and led…

Article Jun 27, 2020 with topic Biomarker, Metabolic Disorders

Read more
Testing of Novel Treatment Options for Niemann-Pick Disease

The search for causative treatments continues to be a leading challenge in rare disease research. Using varying models, researchers recently investigated the potential effects of a novel candidate drug for improving…

Article Jun 24, 2020 with topic Biomarker, Metabolic Disorders, Neurology

Read more
Revealing Genetic Causes of Parkinson’s Disease

Certain variants in LRRK2 have been associated with Parkinson’s disease. While much is known about this association for some variants, knowledge is still sparse for others. In the frame of a CENTOGENE-led clinical study,…

Article Jun 24, 2020 with topic Neurology, NGS, Mutation Database

Read more